Clinical Trials Logo

Clinical Trial Summary

Summary: Controlled, prospective, randomized and randomized clinical trial of two intervention groups (standard care vs. preventive recommendations the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI) of patients diagnosed with sepsis and abdominal post-surgical septic shock with positive results in the risk determination of acute renal injury by NephroCheck® Test that integrates the urinary biomarkers TIMP-2 and IGFBP-7.

Hypothesis: The implementation of a package of preventive measures proposed by the KDIGO guide can reduce the occurrence and severity of acute renal injury in the high-risk abdominal post-surgical septic patient detected by urinary biomarkers for early detection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04222361
Study type Interventional
Source Hospital General Universitario Elche
Contact Maria Mercader Alarcon, MD, DESA
Phone +34696195678
Email mariamercader@hotmail.com
Status Recruiting
Phase N/A
Start date October 2020
Completion date November 2022

See also
  Status Clinical Trial Phase
Recruiting NCT02384525 - The Assessment of Volume Status by BIA and Lung Ultrasound in Septic AKI Patients Undergoing CRRT N/A